Inteum Company
Links
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - matthew+cyr
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Siglec-6 Targeting Antibodies for Precision Immunotherapy
Antibody-Based Platform for Targeted Elimination of Leukemia Cells with Reduced Off-Target Toxicity These human antibodies target and bind to Siglec-6 for precise immunotherapies treating diseases related to aberrant Siglec-6 expression, such as chronic lymphocytic leukemia (CLL). Chronic lymphocytic leukemia (CLL) is one of the most common adult leukemias,...
Published: 5/14/2026
|
Updated: 5/14/2026
|
Inventor(s):
Christoph Rader
,
Matthew Cyr
Keywords(s):
Category(s):
Technology Classifications > Human Health Care > Diagnostics
,
Technology Classifications > Human Health Care > Therapeutics